Monday, October 17, 2016

Ambulance patients face long A&E delays

Thousands of patients taken to hospital by ambulance face long delays before being seen by accident and emergency staff, figures for England show.

Sunday, October 16, 2016

Thursday, October 13, 2016

Many people don't know own blood pressure or cholesterol levels

(Reuters Health) - People who go online to check their risk for cardiovascular disease often don't know two key numbers for assessing heart health: blood pressure and cholesterol levels, a U.K. study suggests.

Wednesday, October 12, 2016

Big Data Unearths New QT-Extending Drug Interaction (CME/CE)

(MedPage Today) -- Health records, lab tests turn up antibiotic/PPI combo that prolongs QT interval

Sunday, October 9, 2016

Medics dash to rural Haiti as cholera kills 13 in Matthew's wake

PORT SALUT, Haiti/PORT-AU-PRINCE (Reuters) - Cholera has killed at least 13 people in southwest Haiti in the wake of Hurricane Matthew, officials said on Saturday, as government teams fanned out across the hard-hit southwestern tip of the country to repair treatment centers and reach the epicenter of one outbreak.

Saturday, October 8, 2016

Medics head to southwest Haiti as Cholera kills 13 in Matthew's wake

PORT-AU-PRINCE/LES CAYES, Haiti (Reuters) - Cholera has killed at least 13 people in southwest Haiti in the wake of Hurricane Matthew, government officials told Reuters on Saturday, as health workers sought to reach the epicenter of one outbreak.

Thursday, October 6, 2016

Most U.S. dermatologists receive industry money

By Andrew M. Seaman (Reuters Health) - Nearly three-quarters of U.S. dermatologists received payments worth a collective $34 million from drug companies in 2014, according to a new analysis of a public database. "Most dermatologist in the U.S. – about 73 percent according to this database – received some form of payment from industry," said lead author Dr. Marie Leger, a dermatologist at Weill Cornell Medicine and NewYork-Presbyterian in New York City. "That being said, most dermatologists get a modest amount from industry." It's difficult to know what these payments mean, but seeing how money flows from industry to the dermatology profession is important to understanding the relationship between those two groups, Leger told Reuters Health.